Believe what you want Reg.
What I've written is factual and accurate.
I think it's unlikely that the FDA will grant accelerated approval for a secondary endpoint of a failed clinical trial. They've said they'll look at it because SI asked them to consider it. That's all.
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-447
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.035(2.97%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $2.475M | 2.157M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 94254 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 9865 | 12 |
View Market Depth
| Last trade - 12.35pm 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |